Macdonald RL - Search Results

1

Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials.

Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Frey A, Marr A, Roux S, Kassell NF. Macdonald RL, et al. Neurocrit Care. 2010 Dec;13(3):416-24. doi: 10.1007/s12028-010-9433-3. Neurocrit Care. 2010. PMID: 20838933 Free article.

2

Percutaneous transluminal angioplasty for cerebral vasospasm after subarachnoid hemorrhage.

Coyne TJ, Montanera WJ, Macdonald RL, Wallace MC. Coyne TJ, et al. Among authors: macdonald rl. Can J Surg. 1994 Oct;37(5):391-6. Can J Surg. 1994. PMID: 7922900 Clinical Trial.

3

Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage.

Macdonald RL, Rosengart A, Huo D, Karrison T. Macdonald RL, et al. J Neurosurg. 2003 Oct;99(4):644-52. doi: 10.3171/jns.2003.99.4.0644. J Neurosurg. 2003. PMID: 14567598 Clinical Trial.

4

Subarachnoid hemorrhage grading scales: a systematic review.

Rosen DS, Macdonald RL. Rosen DS, et al. Among authors: macdonald rl. Neurocrit Care. 2005;2(2):110-8. doi: 10.1385/NCC:2:2:110. Neurocrit Care. 2005. PMID: 16159052 Review.

5

Absence of acute cerebral vasoconstriction after cocaine-associated subarachnoid hemorrhage.

Boco T, Macdonald RL. Boco T, et al. Among authors: macdonald rl. Neurocrit Care. 2004;1(4):449-54. doi: 10.1385/NCC:1:4:449. Neurocrit Care. 2004. PMID: 16174948

6

Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale.

Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr, MacDonald RL, Mayer SA. Frontera JA, et al. Among authors: macdonald rl. Neurosurgery. 2006 Jul;59(1):21-7; discussion 21-7. doi: 10.1227/01.neu.0000243277.86222.6c. Neurosurgery. 2006. PMID: 16823296

7

Cerebral vasospasm: looking beyond vasoconstriction.

Hansen-Schwartz J, Vajkoczy P, Macdonald RL, Pluta RM, Zhang JH. Hansen-Schwartz J, et al. Among authors: macdonald rl. Trends Pharmacol Sci. 2007 Jun;28(6):252-6. doi: 10.1016/j.tips.2007.04.002. Epub 2007 Apr 26. Trends Pharmacol Sci. 2007. PMID: 17466386

8

Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution.

Macdonald RL, Pluta RM, Zhang JH. Macdonald RL, et al. Nat Clin Pract Neurol. 2007 May;3(5):256-63. doi: 10.1038/ncpneuro0490. Nat Clin Pract Neurol. 2007. PMID: 17479073 Review.

9

Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.

Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A; CONSCIOUS-1 Investigators. Macdonald RL, et al. Stroke. 2008 Nov;39(11):3015-21. doi: 10.1161/STROKEAHA.108.519942. Epub 2008 Aug 7. Stroke. 2008. PMID: 18688013 Clinical Trial.

10

Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage.

Jang YG, Ilodigwe D, Macdonald RL. Jang YG, et al. Among authors: macdonald rl. Neurocrit Care. 2009;10(1):141-7. doi: 10.1007/s12028-008-9147-y. Epub 2008 Sep 23. Neurocrit Care. 2009. PMID: 18810661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

763 results

Search Page

Filters